SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Not Allowed)
NIH will soon offer funding for small businesses with recent SBIR/STTR Phase II/IIB awards to support technical assistance and late-stage R&D for commercialization, excluding clinical trials.
Funder: National Institutes of Health
Due Dates: April 5, 2029 (Full application submission deadline)
Funding Amounts: No specified ceiling or floor; award size and duration vary by project scope.
Summary: Supports U.S. small businesses in advancing NIH-funded SBIR/STTR projects from late-stage development to commercialization, including technical and regulatory assistance.
Key Information: Only U.S. small business concerns (SBCs) are eligible to apply.
Description
The Commercialization Readiness Pilot (CRP) Program is designed to help United States small business concerns (SBCs) transition NIH-funded SBIR or STTR projects from late-stage development to successful commercialization. The program provides support for research and development (R&D) activities and technical assistance not typically covered by Phase II or Phase IIB awards. Eligible activities include independent replication or confirmation of key studies, IND- or IDE-enabling studies, clinical studies, manufacturing scale-up, regulatory support, and other specialized technical services. The CRP allows substantial subcontracting to achieve project goals.
